Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genetic Markers”

277 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 277 results

Not applicableUnknownNCT00497887
What this trial is testing

Genetic- and Biological-Markers of Predisposition to Atherosclerosis: Leipzig-Heart Study

Who this might be right for
AtherosclerosisCoronary ArteriosclerosisCarotid Artery Diseases+2 more
University of Leipzig 4,000
Not applicableLooking for participantsNCT02965326
What this trial is testing

Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients

Who this might be right for
Cystic Fibrosis
Hôpital Necker-Enfants Malades 75
Not applicableStudy completedNCT00001885
What this trial is testing

Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis

Who this might be right for
HealthyPulmonary FibrosisRheumatoid Arthritis
National Heart, Lung, and Blood Institute (NHLBI) 400
Not applicableStudy completedNCT01241890
What this trial is testing

Prevention of CF Exacerbation in Childhood: PREVEC Study

Who this might be right for
Cystic FibrosisChildrenExhaled Breath Condensate+4 more
Maastricht University Medical Center 49
Not applicableNot Yet RecruitingNCT07345403
What this trial is testing

GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Analyses, and Pre- and Intraoperative Clinical Data - to Predict Early Complications After Cardiac Surgery.

Who this might be right for
Postoperative Delirium (POD)Postoperative BleedingAcute Kidney Injury+2 more
Medical University of Gdansk 3,000
Not applicableStudy completedNCT03977870
What this trial is testing

Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis

Who this might be right for
Venous Thromboembolism (VTE)
Assistance Publique Hopitaux De Marseille 843
Not applicableStudy completedNCT01767181
What this trial is testing

Light and Exercise in Night-shift Workers

Who this might be right for
Healthy Night Shift Workers
Universitätsklinikum Hamburg-Eppendorf 154
Not applicableEnded earlyNCT00897806
What this trial is testing

Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
M.D. Anderson Cancer Center 7
Not applicableStudy completedNCT00789516
What this trial is testing

The Change of Coagulation Markers in Children With β-thalassemia Disease After Stem Cell Transplantation

Who this might be right for
Thalassemia
Mahidol University 60
Not applicableStudy completedNCT00001206
What this trial is testing

Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit and Disruptive Behavior DisorderAttention Deficit Disorder With Hyperactivity
National Institute of Mental Health (NIMH) 347
Early research (Phase 1)Study completedNCT00055991
What this trial is testing

Bexarotene in Preventing Breast Cancer in Women at Genetic Risk

Who this might be right for
Breast Cancer
Baylor Breast Care Center 87
Not applicableStudy completedNCT00001500
What this trial is testing

Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits

Who this might be right for
Acquired Immunodeficiency SyndromeAlcoholismHIV Infection+2 more
National Cancer Institute (NCI) 4,500
Not applicableLooking for participantsNCT06529237
What this trial is testing

Malaria Molecular Surveillance in Mozambique (Phase 2)

Who this might be right for
MalariaFalciparum MalariaMalaria in Pregnancy
Centro de Investigacao em Saude de Manhica 18,750
Large-scale testing (Phase 3)Study completedNCT01087801
What this trial is testing

Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers

Who this might be right for
Pancreatic Disease
ChiRhoClin, Inc. 64
Not applicableLooking for participantsNCT03855657
What this trial is testing

Biobank - Investigating the Gut Microbiota, Genetics, Epigenetics and Metabolites

Who this might be right for
Inflammatory Bowel Diseases
Chinese University of Hong Kong 6,000
Not applicableLooking for participantsNCT03568630
What this trial is testing

Blood Markers of Early Pancreas Cancer

Who this might be right for
Diabetes Mellitus, Type 2PreDiabetesPancreas Cyst+3 more
University of Nebraska 1,250
Testing effectiveness (Phase 2)UnknownNCT00884767
What this trial is testing

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Who this might be right for
Chemotherapeutic Agent ToxicityColorectal CancerNeurotoxicity
Institut Cancerologie de l'Ouest 206
Not applicableUnknownNCT05375331
What this trial is testing

Clinical and Genetic Markers of Bone Metabolism in Children Under One Year

Who this might be right for
Bone Remodeling DisorderChild DevelopmentGenetic Change
West Kazakhstan Medical University 245
Testing effectiveness (Phase 2)Study completedNCT00519363
What this trial is testing

Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors

Who this might be right for
Systemic Lupus Erythematosus
The Center for Rheumatic Disease, Allergy, & Immunology 15
Post-approval studies (Phase 4)Study completedNCT01034579
What this trial is testing

The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial

Who this might be right for
Relapsing Multiple Sclerosis
EMD Serono 324
Load More Results